BRPI1014039A2 - 6-(3-aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas - Google Patents
6-(3-aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinasInfo
- Publication number
- BRPI1014039A2 BRPI1014039A2 BRPI1014039A BRPI1014039A BRPI1014039A2 BR PI1014039 A2 BRPI1014039 A2 BR PI1014039A2 BR PI1014039 A BRPI1014039 A BR PI1014039A BR PI1014039 A BRPI1014039 A BR PI1014039A BR PI1014039 A2 BRPI1014039 A2 BR PI1014039A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrimidines
- aza
- bicyclo
- hex
- phenyl
- Prior art date
Links
- BRTIDZXATDUKLX-UHFFFAOYSA-N 3-(2-phenylpyrimidin-4-yl)-3-azabicyclo[3.1.0]hexane Chemical class C1C2CC2CN1C(N=1)=CC=NC=1C1=CC=CC=C1 BRTIDZXATDUKLX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2009051486 | 2009-04-08 | ||
| PCT/IB2010/051499 WO2010116328A2 (en) | 2009-04-08 | 2010-04-07 | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1014039A2 true BRPI1014039A2 (pt) | 2018-04-03 |
Family
ID=42936647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014039A BRPI1014039A2 (pt) | 2009-04-08 | 2010-04-07 | 6-(3-aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8288385B2 (pt) |
| EP (1) | EP2417128B1 (pt) |
| JP (1) | JP5536873B2 (pt) |
| KR (1) | KR101694563B1 (pt) |
| CN (1) | CN102369197B (pt) |
| AU (1) | AU2010233378A1 (pt) |
| BR (1) | BRPI1014039A2 (pt) |
| CA (1) | CA2756542C (pt) |
| CL (1) | CL2011002467A1 (pt) |
| ES (1) | ES2567311T3 (pt) |
| IL (1) | IL215517A0 (pt) |
| MA (1) | MA33260B1 (pt) |
| MX (1) | MX2011010200A (pt) |
| NZ (1) | NZ596213A (pt) |
| RU (1) | RU2011144763A (pt) |
| SG (1) | SG175075A1 (pt) |
| WO (1) | WO2010116328A2 (pt) |
| ZA (1) | ZA201108158B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200640877A (en) | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
| AR063258A1 (es) | 2006-10-13 | 2009-01-14 | Actelion Pharmaceuticals Ltd | Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos. |
| AR063518A1 (es) | 2006-10-25 | 2009-01-28 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis |
| ES2388958T3 (es) | 2007-11-29 | 2012-10-22 | Actelion Pharmaceuticals Ltd. | Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12 |
| AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
| AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
| EP2421859B1 (en) | 2009-04-22 | 2014-04-09 | Actelion Pharmaceuticals Ltd. | Thiazole derivatives and their use as p2y12 receptor antagonists |
| NZ628587A (en) | 2012-03-06 | 2016-07-29 | Boehringer Ingelheim Int | Benzodioxanes in combination with other actives for inhibiting leukotriene production |
| EP2968737A4 (en) * | 2013-03-15 | 2016-11-09 | Concert Medical Llc | METHOD AND SYSTEM FOR THE CONTROLLED ADMINISTRATION OF A FLUID TO A PATIENT AND / OR FOR THE CONTROLLED REMOVAL OF A FLUID FROM THE BODY OF THE PATIENT |
| SI3397631T1 (sl) * | 2015-12-29 | 2022-01-31 | Pfizer Inc. | Substituirani 3-azabiciklo(3.1.0)heksani kot zaviralci ketoheksokinaze |
| ES2886840T3 (es) | 2016-08-31 | 2021-12-21 | Eisai R&D Man Co Ltd | Compuesto de pirazolo[1,5-a]pirimidina |
| HUE057772T2 (hu) | 2016-09-22 | 2022-06-28 | Idorsia Pharmaceuticals Ltd | Kristályos formák |
| US11179390B2 (en) | 2017-03-15 | 2021-11-23 | Idorsia Pharmaceuticals Ltd | Subcutaneous administration of a P2Y12 receptor antagonist |
| PH12021551635A1 (en) | 2019-01-29 | 2022-05-02 | Shandong Xuanzhu Pharma Co Ltd | Hexone glucokinase inhibitor and use thereof |
| WO2020243423A1 (en) | 2019-05-31 | 2020-12-03 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| KR20220030222A (ko) | 2019-05-31 | 2022-03-10 | 이케나 온콜로지, 인코포레이티드 | Tead 억제제 및 이의 용도 |
| GB202001856D0 (en) * | 2020-02-11 | 2020-03-25 | Inorbit Therapeutics Ab | Compounds useful in inhibiting ketohexokinase and methods of making and using the same |
| CA3188340A1 (en) | 2020-08-13 | 2022-02-17 | Boehringer Ingelheim International Gmbh | Treatment of cognitive impairement associated with schizophrenia |
| CA3195702A1 (en) | 2020-10-13 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Process of reworking |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5373586A (en) | 1976-12-09 | 1978-06-30 | Mitsubishi Chem Ind Ltd | New penicillin derivatives |
| US6861424B2 (en) * | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
| OA12970A (en) * | 2002-12-11 | 2006-10-13 | Schering Ag | 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists. |
| CA2521313A1 (en) | 2003-04-09 | 2004-10-28 | Wyeth | Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.o)non-1(7)-3n-2-yl)-al kyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| TW200640877A (en) * | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
| WO2007046075A1 (en) | 2005-10-21 | 2007-04-26 | Actelion Pharmaceuticals Ltd | Piperazine derivatives as antimalarial agents |
| WO2008031556A2 (en) | 2006-09-12 | 2008-03-20 | Ucb Pharma, S.A. | 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| AR063258A1 (es) | 2006-10-13 | 2009-01-14 | Actelion Pharmaceuticals Ltd | Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos. |
| AR063518A1 (es) | 2006-10-25 | 2009-01-28 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis |
| KR20100015886A (ko) | 2007-04-23 | 2010-02-12 | 사노피-아벤티스 | Ｐ2ｙ12 길항제로서의 퀴놀린-카복스아미드 유도체 |
| TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
| ES2388958T3 (es) | 2007-11-29 | 2012-10-22 | Actelion Pharmaceuticals Ltd. | Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12 |
| EP2238128B1 (en) | 2007-12-26 | 2012-08-22 | Sanofi | Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| WO2009080227A2 (en) | 2007-12-26 | 2009-07-02 | Sanofi-Aventis | Pyrazole-carboxamide derivatives as p2y12 antagonists |
| AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
| AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
| EP2421859B1 (en) | 2009-04-22 | 2014-04-09 | Actelion Pharmaceuticals Ltd. | Thiazole derivatives and their use as p2y12 receptor antagonists |
-
2010
- 2010-04-07 KR KR1020117023353A patent/KR101694563B1/ko not_active Expired - Fee Related
- 2010-04-07 SG SG2011072584A patent/SG175075A1/en unknown
- 2010-04-07 RU RU2011144763/04A patent/RU2011144763A/ru not_active Application Discontinuation
- 2010-04-07 US US13/263,089 patent/US8288385B2/en active Active
- 2010-04-07 NZ NZ596213A patent/NZ596213A/xx not_active IP Right Cessation
- 2010-04-07 AU AU2010233378A patent/AU2010233378A1/en not_active Abandoned
- 2010-04-07 CA CA2756542A patent/CA2756542C/en active Active
- 2010-04-07 JP JP2012504121A patent/JP5536873B2/ja not_active Expired - Fee Related
- 2010-04-07 BR BRPI1014039A patent/BRPI1014039A2/pt not_active IP Right Cessation
- 2010-04-07 CN CN2010800144737A patent/CN102369197B/zh not_active Expired - Fee Related
- 2010-04-07 ES ES10715600T patent/ES2567311T3/es active Active
- 2010-04-07 MX MX2011010200A patent/MX2011010200A/es not_active Application Discontinuation
- 2010-04-07 EP EP10715600.2A patent/EP2417128B1/en active Active
- 2010-04-07 MA MA34332A patent/MA33260B1/fr unknown
- 2010-04-07 WO PCT/IB2010/051499 patent/WO2010116328A2/en not_active Ceased
-
2011
- 2011-10-04 CL CL2011002467A patent/CL2011002467A1/es unknown
- 2011-10-04 IL IL215517A patent/IL215517A0/en unknown
- 2011-11-07 ZA ZA2011/08158A patent/ZA201108158B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG175075A1 (en) | 2011-11-28 |
| CN102369197A (zh) | 2012-03-07 |
| RU2011144763A (ru) | 2013-05-20 |
| US20120028989A1 (en) | 2012-02-02 |
| ZA201108158B (en) | 2014-04-30 |
| JP5536873B2 (ja) | 2014-07-02 |
| CN102369197B (zh) | 2013-11-06 |
| ES2567311T3 (es) | 2016-04-21 |
| NZ596213A (en) | 2013-05-31 |
| MX2011010200A (es) | 2011-10-14 |
| WO2010116328A3 (en) | 2011-01-13 |
| CA2756542C (en) | 2017-08-22 |
| CL2011002467A1 (es) | 2012-02-24 |
| EP2417128A2 (en) | 2012-02-15 |
| JP2012523406A (ja) | 2012-10-04 |
| EP2417128B1 (en) | 2016-03-02 |
| AU2010233378A1 (en) | 2011-11-24 |
| WO2010116328A2 (en) | 2010-10-14 |
| US8288385B2 (en) | 2012-10-16 |
| KR101694563B1 (ko) | 2017-01-09 |
| IL215517A0 (en) | 2011-12-29 |
| CA2756542A1 (en) | 2010-10-14 |
| MA33260B1 (fr) | 2012-05-02 |
| KR20120070627A (ko) | 2012-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1014039A2 (pt) | 6-(3-aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas | |
| BRPI1006113A2 (pt) | "derivado de piridina". | |
| ME02397B (me) | Pirazolo[1,5-a]pirimidini i -triazini kao antiviralni agensi | |
| IL210176A0 (en) | Substituted pyrimidone derivatives | |
| BRPI0907435A2 (pt) | Derivados de 5-flúor pirimidina | |
| BR112012000763A2 (pt) | derivados de piridin-4-ila | |
| BRPI1013760A2 (pt) | compostos anticâncer de amino pirimidina. | |
| BRPI1011747A2 (pt) | artigo não tecido funcionalizado. | |
| EP2471786A4 (en) | aminopyrazole derivative | |
| BRPI0923497A2 (pt) | derivados de piridazinona | |
| BRPI1008948A2 (pt) | nicotinamida substituída como moduladores kcnq2/3. | |
| IL213953A0 (en) | Fused pyrimidines | |
| BRPI0914662A2 (pt) | derivados de triazinona substituída | |
| IL212636A0 (en) | Pyridazinone derivatives | |
| IL218481A0 (en) | Herbicidal pyrimidone derivatives | |
| BRPI0911161A2 (pt) | derivado de piridazinona | |
| BRPI0920496A2 (pt) | derivados substituídos de pirimidina etriazina | |
| BRPI0811115A2 (pt) | Compostos de heteroarilamida pirimidona | |
| PL2495243T3 (pl) | Nowa pochodna 5-fluorouracylu | |
| BRPI0914676A2 (pt) | derivados de n-óxido de pirazina substituídos | |
| IL213828A0 (en) | Pyridazinone derivatives | |
| BRPI1016192A2 (pt) | derivados de soxazol. | |
| BRPI0811094A2 (pt) | Derivados de heteroarilamida pirimidona | |
| EP2264026A4 (en) | ALKYLAMINOPYRIDINDERIVATE | |
| EP2502909A4 (en) | aminopyridine derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |